BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8230260)

  • 1. Cancer prevention and control within the National Cancer Institute's clinical trials network: lessons from the Community Clinical Oncology Program.
    Kaluzny AD; Warnecke RB; Lacey LM; Morrissey JP; Gillings D; Ozer H
    J Natl Cancer Inst; 1993 Nov; 85(22):1807-11. PubMed ID: 8230260
    [No Abstract]   [Full Text] [Related]  

  • 2. Update on the National Cancer Institute's clinical trials cooperative group program.
    Wallner PE
    J Am Coll Radiol; 2004 Nov; 1(11):865-6. PubMed ID: 17411719
    [No Abstract]   [Full Text] [Related]  

  • 3. Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.
    Kaluzny A; Brawley O; Garson-Angert D; Shaw J; Godley P; Warnecke R; Ford L
    J Natl Cancer Inst; 1993 Dec; 85(23):1945-50. PubMed ID: 8230286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The National Cancer Institute's Smoking, Tobacco, and Cancer Program.
    Cullen JW
    Chest; 1989 Jul; 96(1 Suppl):9S-13S. PubMed ID: 2737004
    [No Abstract]   [Full Text] [Related]  

  • 5. The National Cancer Institute's Cancer Prevention Research Program.
    DeWys WD; Costlow RD; Malone WF
    J Occup Med; 1986 Oct; 28(10):902-5. PubMed ID: 3772546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The National Cancer Institute's intervention trials.
    Cullen JW
    Cancer; 1988 Oct; 62(8 Suppl):1851-64. PubMed ID: 3048640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of managed care and competition on community-based clinical research.
    Carpenter WR; Weiner BJ; Kaluzny AD; Domino ME; Lee SY
    Med Care; 2006 Jul; 44(7):671-9. PubMed ID: 16799362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The advantages of using the clinical trials model for cancer control research.
    La Chance PA; Vogt TM; Lichtenstein E
    Prog Clin Biol Res; 1990; 339():383-9. PubMed ID: 2202997
    [No Abstract]   [Full Text] [Related]  

  • 9. Adapting clinical trials networks to promote cancer prevention and control research.
    Weiner BJ; McKinney MM; Carpenter WR
    Cancer; 2006 Jan; 106(1):180-7. PubMed ID: 16333855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer and AIDS: National Cancer Institute's investment in research.
    Feigal EG; Black JB
    Res Initiat Treat Action; 2003; 9(1):26-9. PubMed ID: 14971363
    [No Abstract]   [Full Text] [Related]  

  • 11. Achieving high cancer control trial enrollment in the community setting: an analysis of the Community Clinical Oncology Program.
    Jacobs SR; Weiner BJ; Minasian LM; Good MJ
    Contemp Clin Trials; 2013 Mar; 34(2):320-5. PubMed ID: 23295315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the National Cancer Institute's Data-based Intervention Research program on state health agencies.
    Steckler A; Goodman RM; Alciati MH
    Health Educ Res; 1997 Jun; 12(2):199-211. PubMed ID: 10168573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
    Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
    Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of U.S. National Cancer Institute (USNCI) chemoprevention research.
    Johnson KA; Ford LG; Kramer B; Greenwald P
    Acta Oncol; 1994; 33(1):5-11. PubMed ID: 8142125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer control research for community programs: the National Cancer Institute initiative.
    Hunter CP; Bavier AR; Ford LG
    Cancer Detect Prev; 1990; 14(6):633-7. PubMed ID: 2257561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Outcomes of Cancer Outcomes Research: focusing on the National Cancer Institute's quality-of-care initiative.
    Lipscomb J; Snyder CF
    Med Care; 2002 Jun; 40(6 Suppl):III3-10. PubMed ID: 12064755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of cancer prevention and control.
    Weed DL; Greenwald P; Cullen JW
    Semin Oncol; 1990 Aug; 17(4):504-9. PubMed ID: 2201093
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluating organizational design to assure technology transfer: the case of the Community Clinical Oncology Program.
    Kaluzny AD; Ricketts T; Warnecke R; Ford L; Morrissey J; Gillings D; Sondik EJ; Ozer H; Goldman J
    J Natl Cancer Inst; 1989 Nov; 81(22):1717-25. PubMed ID: 2681795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute.
    DeWys WD; Greenwald P
    Semin Oncol; 1983 Sep; 10(3):360-4. PubMed ID: 6665563
    [No Abstract]   [Full Text] [Related]  

  • 20. Community Clinical Oncology Program as a recruitment vehicle for cancer control research. The Southeast Cancer Control Consortium experience.
    Paskett ED; Cooper MR; DeGraffinreid CR; Spurr CL; Dolecek TA
    N C Med J; 1995 Jun; 56(6):283-6. PubMed ID: 7603584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.